Navigation

Psoriasis - ustekinumab

Ustekinumab for the treatment of moderate to severe psoriasis

Status: History
Expected date of issue: September 2009
Referral date: June 2008
Process: STA
Topic area:
  • Skin
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Sally Gallaugher
Communications manager: Tonya Gillis
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 08 January 2009
1st appraisal committee meeting: 22 April 2009
2nd appraisal committee meeting 24 June 2009
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers/sponsors

  • Janssen-Cilag (ustekinumab)

Patient/carer groups

  • Afiya Trust
  • Age Concern England
  • Black Health Agency
  • British Ethnic Health Awareness  Foundation (BEHAF)
  • Changing Faces
  • Chinese National Healthy Living Centre
  • Confederation of Indian Organisations
  • Counsel and Care
  • Equalities National Council
  • Help the Aged
  • Let's Face It
  • Muslim Council of Great Britain
  • Muslim Health Network
  • Psoriasis Association
  • Psoriasis and Psoriatic Arthritis Alliance
  • Skin Care Campaign
  • South Asian Health Foundation
  • Specialised Healthcare Alliance

Professional groups

  • British Association for Services to the Elderly
  • British Association of Dermatologists
  • British Dermatological Nursing Group
  • British Geriatrics Society
  • British Skin Foundation
  • Primary Care Dermatology Society
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Physicians
  • Royal Pharmaceutical Society
  • Royal Society of Medicine – Intellectual Disabilities Forum
  • United Kingdom Clinical Pharmacy Association

Others

  • Department of Health
  • Dorset PCT
  • Sandwell PCT
  • Welsh Assembly Government

General

  • Age Concern Cymru
  • Board of Community Health Councils in Wales
  • British National Formulary
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Medicines and Healthcare products Regulatory Agency
  • National Association of Primary Care
  • National Public Health Service for Wales
  • NHS Alliance
  • NHS Confederation
  • NHS Purchasing and Supply Agency
  • NHS Quality Improvement Scotland
  • Scottish Medicines Consortium

Comparator manufacturers

  • Abbott Laboratories (adalimumab)
  • Schering-Plough (infliximab)
  • Merck Serono (efalizumab)
  • Wyeth Pharmaceuticals (etanercept)

Relevant research groups

  • British Epidermo-Epidemiology Society
  • Centre of Evidence-based Dermatology, University of Nottingham
  • MRC Clinical Trials Unit
  • National Institute of Health Research
  • Policy Research Institute on Ageing and Ethnicity
  • Research Institute of the Care of the Elderly
  • Skin Research Centre, University of Leeds
  • Skin Treatment and Research Trust (START
  • United Kingdom Clinical Research Network

Evidence Review Group

  • Southampton Health Technology Assessment Centre (SHTAC), University of Southampton
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.